HIV/AIDS Vaccine
Neutralizing antibodies do not mediate suppression of HIV in elite suppressors
Published in AIDS Weekly, July 17th, 2006
According to scientists in the United States, "Neutralizing antibodies (NAb) against autologous virus can reach high titers in human immunodeficiency virus type 1 (HIV-1)-infected patients with progressive disease. Less is known about the role of NAb in HIV-1-infected patients with viral loads of <50 copies/ml of plasma, including patients on effective highly active antiretroviral therapy (HAART) and elite suppressors, who control HIV-1 replication without...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-07-17)
More Articles from AIDS Weekly
- DNA Research
APOBEC3G DNA deaminase acts processively 3'->5' on single-stranded DNA - HIV/AIDS Drug Development
Fumagillin suppresses HIV-1 infection of macrophages through Vpr activity inhibition - HIV/AIDS Drug Resistance
HAART resistance prevalence higher among recent versus established HIV infections - HIV/AIDS Pathogenesis
HIV-1 subtype C Envs elicit potent yet restricted neutralizing antibody response in early infection - Target Gene Delivery
HIV-1 RT modifications in vector systems deliver target genes to tumor cells - Avian Influenza
Adventrx presents broad antiviral activity for Thiovir - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
